Lexicon Pharmaceuticals

Filed a patent for "use of sotagliflozin for the treatment of patients with type 1 diabetes mellitus" on Thu, July 11, 2024

Filed a patent for "compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2" on Thu, July 13, 2023

Filed a patent for "solid forms of (s)-1-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof" on Thu, November 9, 2023

Filed a patent for "methods and compounds useful in the synthesis of an aak1 inhibitor" on Thu, November 9, 2023

Filed a patent for "compounds and methods for treating spasticity" on Thu, October 19, 2023

Filed a patent for "sotagliflozin for improving left atrial function" on Thu, March 28, 2024

Filed a patent for "compounds and methods for treating spasticity" on Fri, April 15, 2022